Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.

@article{Lavey1990ImpactOS,
  title={Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.},
  author={Robert S. Lavey and Nancy L. Eby and Leonard R. Prosnitz},
  journal={Cancer},
  year={1990},
  volume={66 1},
  pages={
          80-8
        }
}
The risk of a second malignancy was determined for 999 patients given primary treatment using chemotherapy only, radiation therapy only, or both for Hodgkin's Disease or a non-Hodgkin's lymphoma at Duke University Medical Center between 1970 and 1981. The incidence, 10-year actuarial risk, and relative risk of developing an acute leukemia, solid tumor, or second lymphoma were determined by treatment modality and initial lymphoma type. Among the 313 Hodgkin's disease patients, the acute leukemia… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis.

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

What’s All the Fuss About? Facts and Figures About Bone Marrow Failure and Conditions

VIEW 2 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

Second primary malignancies after treatment for malignant lymphoma

VIEW 3 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Incidence of myelodysplastic syndromes in patients receiving concurrent myelosuppressive chemotherapy and pegfilgrastim

VIEW 1 EXCERPT
CITES BACKGROUND